ARS Pharmaceuticals
(NASDAQ) SPRY
ARS Pharmaceuticals Financials at a Glance
Market Cap
$824.17M
Revenue (TTM)
$84.28M
Net Income (TTM)
$171.30M
EPS (TTM)
$-1.74
P/E Ratio
-4.78
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$8.29
Volume
42,619
Open
$7.88
Price
$8.29
Volume
42,619
Open
$7.88
Previous Close
$8.29
Daily Range
$7.75 - $8.30
52-Week Range
$6.66 - $18.90
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$8.29
Volume
42,619
Open
$7.88
Previous Close
$8.29
Daily Range
$7.75 - $8.30
52-Week Range
$6.66 - $18.90
SPRY News
SPRY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ARS Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
158
CEO
Richard E. Lowenthal, MBA
Website
www.ars-pharma.comHeadquarters
San Diego, CA 92130, US
SPRY Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-92%
Return on Capital
-62%
Return on Assets
-52%
Earnings Yield
-20.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$824.17M
Shares Outstanding
99.30M
Volume
42.62K
Short Interest
0.00%
Avg. Volume
1.48M
Financials (TTM)
Gross Profit
$63.85M
Operating Income
$179.45M
EBITDA
$178.08M
Operating Cash Flow
$170.87M
Capital Expenditure
$339.00K
Free Cash Flow
$171.21M
Cash & ST Invst.
$244.99M
Total Debt
$96.96M
ARS Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$28.09M
-67.6%
Gross Profit
$24.89M
-69.9%
Gross Margin
88.60%
N/A
Market Cap
$824.17M
N/A
Market Cap/Employee
$5.32M
N/A
Employees
155
N/A
Net Income
$41.32M
-182.8%
EBITDA
$41.05M
-186.9%
Quarterly Fundamentals
Net Cash
$148.02M
-52.9%
Accounts Receivable
$25.35M
+176.7%
Inventory
$8.37M
+60.6%
Long Term Debt
$96.37M
N/A
Short Term Debt
$588.00K
+1300.0%
Return on Assets
-52.28%
N/A
Return on Invested Capital
-62.20%
N/A
Free Cash Flow
$43.48M
-204.3%
Operating Cash Flow
$43.48M
-203.5%